我国CRO公司与国际CRO公司的管理对比分析

摘要

近年来,资金和技术的匮乏始终制约着中国药企的新药研发进程.随着社会经济和科技的蓬勃发展,承担医药研发外包服务的CRO公司,以其雄厚的资本基础和专业的研究技术,有效弥补了中国制药行业的研发缺陷. 如何汲取国际CRO公司的管理模式和经验来改善自身现状,成为中国CRO公司面临的重要课题.%In recent years, the lack of funds and technology always restrict Chinese pharmaceutical drug development process.With the rapid development of social economy and technology, the CRO company, which undertakes medical researchand development outsourcing services, has made up the defects of China's pharmaceutical industry by its strong capital baseand professional research technology. How to learn from the management mode and experience of CRO company to improveits current situation, become an important issue of China CRO company.